Control and elimination of lymphatic filariasis in Oceania: Prevalence, geographical distribution, mass drug administration, and surveillance in Samoa, 1998-2017.

3区医学 Q1 Immunology and Microbiology

Advances in Parasitology Pub Date : 2021-01-01 Epub Date: 2021-08-09 DOI:10.1016/bs.apar.2021.03.002

Patricia M Graves, Hayley Joseph, Shaun P Coutts, Helen J Mayfield, Fuatai Maiava, Tile Ann Ah Leong-Lui, Palanitina Tupuimatagi Toelupe, Vailolo Toeaso Iosia, Siatua Loau, Paulo Pemita, Take Naseri, Robert Thomsen, Alvaro Berg Soto, Thomas R Burkot, Peter Wood, Wayne Melrose, Padmasiri Aratchige, Corinne Capuano, Sung Hye Kim, Masayo Ozaki, Aya Yajima, Patrick J Lammie, Eric Ottesen, Lepaitai Hansell, Rasul Baghirov, Colleen L Lau, Kazuyo Ichimori

{"title":"Control and elimination of lymphatic filariasis in Oceania: Prevalence, geographical distribution, mass drug administration, and surveillance in Samoa, 1998-2017.","authors":"Patricia M Graves, Hayley Joseph, Shaun P Coutts, Helen J Mayfield, Fuatai Maiava, Tile Ann Ah Leong-Lui, Palanitina Tupuimatagi Toelupe, Vailolo Toeaso Iosia, Siatua Loau, Paulo Pemita, Take Naseri, Robert Thomsen, Alvaro Berg Soto, Thomas R Burkot, Peter Wood, Wayne Melrose, Padmasiri Aratchige, Corinne Capuano, Sung Hye Kim, Masayo Ozaki, Aya Yajima, Patrick J Lammie, Eric Ottesen, Lepaitai Hansell, Rasul Baghirov, Colleen L Lau, Kazuyo Ichimori","doi":"10.1016/bs.apar.2021.03.002","DOIUrl":null,"url":null,"abstract":"<p><p>Lymphatic filariasis (LF) is a major public health problem globally and in the Pacific Region. The Global Programme to Eliminate LF has made great progress but LF is persistent and resurgent in some Pacific countries and territories. Samoa remains endemic for LF despite elimination efforts through multiple two-drug mass drug administrations (MDA) since 1965, including renewed elimination efforts started in 1999 under the Pacific Programme for Elimination of LF (PacELF). Despite eight rounds of national and two rounds of subnational MDA under PacELF, Samoa failed transmission assessment surveys (TAS) in all three evaluation units in 2017. In 2018, Samoa was the first to distribute countrywide triple-drug MDA using ivermectin, diethylcarbamazine (DEC), and albendazole. This paper provides a review of MDAs and historical survey results from 1998 to 2017 in Samoa and highlights lessons learnt from LF elimination efforts, including challenges and potential ways to overcome them to successfully achieve elimination.</p>","PeriodicalId":50854,"journal":{"name":"Advances in Parasitology","volume":" ","pages":"27-73"},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Parasitology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/bs.apar.2021.03.002","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/8/9 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"Immunology and Microbiology","Score":null,"Total":0}

引用次数: 3

Abstract

Lymphatic filariasis (LF) is a major public health problem globally and in the Pacific Region. The Global Programme to Eliminate LF has made great progress but LF is persistent and resurgent in some Pacific countries and territories. Samoa remains endemic for LF despite elimination efforts through multiple two-drug mass drug administrations (MDA) since 1965, including renewed elimination efforts started in 1999 under the Pacific Programme for Elimination of LF (PacELF). Despite eight rounds of national and two rounds of subnational MDA under PacELF, Samoa failed transmission assessment surveys (TAS) in all three evaluation units in 2017. In 2018, Samoa was the first to distribute countrywide triple-drug MDA using ivermectin, diethylcarbamazine (DEC), and albendazole. This paper provides a review of MDAs and historical survey results from 1998 to 2017 in Samoa and highlights lessons learnt from LF elimination efforts, including challenges and potential ways to overcome them to successfully achieve elimination.

查看原文本刊更多论文

大洋洲淋巴丝虫病的控制和消除:1998-2017年萨摩亚的流行、地理分布、大规模给药和监测

淋巴丝虫病是全球和太平洋区域的一个重大公共卫生问题。消除艾滋病全球规划取得了很大进展，但艾滋病在一些太平洋国家和领土持续存在并死灰复燃。尽管自1965年以来通过多种双药大规模药物管理(MDA)进行了消除努力，包括1999年根据太平洋消除LF规划重新开始的消除努力，但萨摩亚仍然流行LF。尽管在太平洋应急计划下开展了8轮国家和2轮次国家级别的大规模预防和预防行动，萨摩亚在2017年的所有三个评估单位的传播评估调查(TAS)中均未通过。2018年，萨摩亚率先在全国范围内分发使用伊维菌素、乙基卡马嗪和阿苯达唑的三药丙二醛。本文回顾了萨摩亚1998年至2017年的多边发展协定和历史调查结果，并强调了从消除低频低频工作中吸取的教训，包括挑战和克服这些挑战以成功实现消除的潜在方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Advances in Parasitology 医学-寄生虫学

CiteScore

9.00

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： Advances in Parasitology is recognised as a leading review serial which is consistently well placed in terms of impact factor and citations. Major reviews on all aspects of medical, veterinary and wild-life parasitology are considered. The journal provides an outlet for authoritative reviews from experts in the field. While emphasis is given to modern molecular approaches contributions across all disciplines are encouraged including traditional areas such as ecology and taxonomy. Eclectic volumes are supplemented by thematic volumes dedicated to a particular topic of recognised interest and importance.